Vita Life Sciences Ltd
Company Profile
Business description
Vita Life Sciences Ltd is an Australian-based pharmaceutical and healthcare company involved in formulating, packaging, selling, and distributing vitamins and supplements. It produces a wide range of premium supplements, vitamins, minerals, herbs, and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, VitaScience, and Herbs of Gold brands throughout the Asia-Pacific region. Vita Life Sciences has two operating segments: VMS Operational, which generates maximum revenue, and VMS Investments. Geographically, the Group generates maximum revenue from Malaysia and Singapore, and the rest from Australia, and China and Vietnam.
Contact
1-5 Chalmers Crescent
Suite 802, Level 8
Mascot
SydneyNSW2020
AUST: +61 295452633
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
Stocks News & Analysis
stocks
Sales shine but broader macro outlook darkens for this ASX share
stocks
Chart of the Week: US equity market trading at an attractive discount
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,168.90 | 43.80 | 0.48% |
| CAC 40 | 8,203.24 | 60.63 | -0.73% |
| DAX 40 | 23,712.39 | 368.24 | -1.53% |
| Dow JONES (US) | 47,867.32 | 42.60 | -0.09% |
| FTSE 100 | 10,586.43 | 22.45 | -0.21% |
| HKSE | 25,752.40 | 140.62 | -0.54% |
| NASDAQ | 22,571.03 | 63.97 | -0.28% |
| Nikkei 225 | 55,895.32 | 413.10 | -0.73% |
| NZX 50 Index | 13,273.81 | 19.87 | 0.15% |
| S&P 500 | 6,774.43 | 8.38 | -0.12% |
| S&P/ASX 200 | 8,973.20 | 57.80 | 0.65% |
| SSE Composite Index | 3,966.17 | 28.83 | -0.72% |